Mercer Global Advisors
BPMC

Mercer Global Advisors’s Blueprint Medicines BPMC Stock Holding History

Mercer Global Advisors’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,610
Closed -$268K – 1803
2021
Q3 		$268K Buy
+2,610
New +$243K ﹤0.01% 1476
2021
Q2 		– Sell
-2,914
Closed -$283K – 1680
2021
Q1 		$283K Buy
+2,914
New +$291K ﹤0.01% 1333
2020
Q3 		– Sell
-4,102
Closed -$320K – 1242
2020
Q2 		$320K Buy
+4,102
New +$277K 0.01% 829

Other funds holding BPMC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Mercer Global Advisors's BPMC Position: Q4 2021 in Review

Mercer Global Advisors sold out of Blueprint Medicines (BPMC) in Q4 2021, closing a stake of 2,610 shares — an estimated $268K sold.

Mercer Global Advisors first reported a position in BPMC in Q2 2020 and held it in 3 quarters. The position peaked at $320K in Q2 2020. 280 funds tracked by Wall St. Rank hold BPMC as of Q4 2021.

  • Mercer Global Advisors reported no remaining Blueprint Medicines position as of Q4 2021 after selling out during the quarter.
  • Mercer Global Advisors sold 2,610 Blueprint Medicines shares in Q4 2021, an estimated $268K.
  • Mercer Global Advisors first reported a position in Blueprint Medicines in Q2 2020 and held it in 3 quarters.
  • Mercer Global Advisors's Blueprint Medicines position peaked at $320K in Q2 2020.
  • 280 funds tracked by Wall St. Rank held Blueprint Medicines as of Q4 2021.

Based on Mercer Global Advisors's 13F filing for Q4 2021, filed 4 Feb 2022.